Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies. Emerging evidence indicates that the tolerization of local dendritic cells (DCs) within the tumor microenvironment promotes immune evasion. Here, we have described a mechanism by which melanomas establish a site of immune privilege via a paracrine Wnt5a-β-catenin-peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling pathway that drives fatty acid oxidation (FAO) in DCs by upregulating the expression of the carnitine palmitoyltransferase-1A (CPT1A) fatty acid transporter. This FAO shift increased the protoporphyrin IX prosthetic group of indoleamine 2,3-dioxgenase-1 (IDO) while suppressing interleukin(IL)-6 and IL-12 cytokine expression, culminating in enhanced IDO activity and the generation of regulatory T cells. We demonstrated that blockade of this pathway augmented anti-melanoma immunity, enhanced the activity of anti-PD-1 antibody immunotherapy, and suppressed disease progression in a transgenic melanoma model. This work implicates a role for tumor-mediated metabolic reprogramming of local DCs in immune evasion and immunotherapy resistance.
Pubmed ID: 29343435 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A commercial graphing software company that offers scientific software for statistical analyses, curve fitting and data analysis. It offers four programs: Prism, InStat, StatMate and QuickCalcs.
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis monoclonal targets PD-1 (CD279)
View all literature mentionsThis unknown targets Goat Mouse IgG (H L)-HRP Conjugate
View all literature mentionsThis unknown targets Goat Rabbit IgG (H L)-HRP Conjugate
View all literature mentionsThis monoclonal targets IL-12/IL-23
View all literature mentionsThis monoclonal targets IL-6
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD86
View all literature mentionsThis monoclonal targets CD80
View all literature mentionsThis monoclonal targets CD40
View all literature mentionsThis monoclonal targets Mouse Foxp3
View all literature mentionsThis monoclonal targets Mouse CD8a
View all literature mentionsThis monoclonal targets CD274
View all literature mentionsThis monoclonal targets Wnt-5a (A-5)
View all literature mentionsThis polyclonal targets
View all literature mentionsThis monoclonal targets AMPK alpha
View all literature mentionsThis monoclonal targets AMPK-alpha, phospho (Thr172)
View all literature mentionsThis polyclonal targets Catenin, beta
View all literature mentionsThis polyclonal targets PPARG
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsOpen source Java based image processing software program designed for scientific multidimensional images. ImageJ has been transformed to ImageJ2 application to improve data engine to be sufficient to analyze modern datasets.
View all literature mentionsMus musculus with name C57BL/6-Foxp3tm1Flv/J from IMSR.
View all literature mentionsMus musculus with name B6.129-Ido1tm1Alm/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6-Tg(TcraTcrb)1100Mjb/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(Tyr-cre/ERT2)13Bos/J from IMSR.
View all literature mentionsMus musculus with name BALB/cJ from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsCell line DC2.4 is a Transformed cell line with a species of origin Mus musculus (Mouse)
View all literature mentions